Literature DB >> 2964056

Pharmacokinetics of synthetic alpha-human atrial natriuretic polypeptide in normal men; effect of aging.

M Ohashi1, N Fujio, H Nawata, K Kato, H Matsuo, H Ibayashi.   

Abstract

We reported that plasma human atrial natriuretic polypeptide (hANP) in healthy aged men was significantly higher than that in young men, presumably due to a diminished cellular response to endogenous hANP in the aged subjects (J. Clin. Endocrinol. Metab., 64 (1987) 81). To examine the effect of age on the metabolic clearance rate for hANP, synthetic alpha-hANP (2 micrograms/kg) was administered intravenously to healthy young (n=6) and aged (n=4) men. The plasma hANP was measured by a direct radioimmunoassay. The disappearance of alpha-hANP from plasma was characterized by a biexponential decay curve, in both groups. There was no difference of the initial phase between young and aged groups (young vs aged; 1.2 +/- 0.2 min vs 2.9 +/- 1.0 min), while the second phase of alpha-hANP disappearance in the aged group was significantly prolonged compared with that in the young individuals (young vs aged; 17.3 +/- 3.9 min vs 34.3 +/- 3.0 min, P less than 0.05). We tentatively conclude that the reduced metabolic clearance rates for hANP were responsible, in part, for the high plasma concentrations in the aged men.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2964056     DOI: 10.1016/0167-0115(87)90168-6

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  6 in total

Review 1.  Clinical aspects of changes in water and sodium homeostasis in the elderly.

Authors:  Christian A Koch; Tibor Fulop
Journal:  Rev Endocr Metab Disord       Date:  2017-03       Impact factor: 6.514

2.  Raised plasma levels of atrial natriuretic factor in cardiac allograft recipients: evidence of increased cardiac secretion and decreased renal clearance.

Authors:  C C Lang; T Moreland; A M Choy; T H Pringle; G P McNeill; A D Struthers
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

Review 3.  Neuroendocrine mechanisms and cardiovascular homeostasis in the elderly.

Authors:  P A Phillips; G P Hodsman; C I Johnston
Journal:  Cardiovasc Drugs Ther       Date:  1991-01       Impact factor: 3.727

4.  Kinetics of atrial natriuretic peptide in young and elderly subjects.

Authors:  A C Tan; T L Jansen; E F Termond; F G Russel; T Thien; P W Kloppenborg; T J Benraad
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 5.  Atrial natriuretic peptide. An overview of clinical pharmacology and pharmacokinetics.

Authors:  A C Tan; F G Russel; T Thien; T J Benraad
Journal:  Clin Pharmacokinet       Date:  1993-01       Impact factor: 6.447

6.  Human pharmacokinetics of an analogue of atrial natriuretic factor.

Authors:  S H Ingwersen; H Eiskjaer; M Schmiegelow; E B Pedersen
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.